There are 2867 resources available
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2: GU tumours, non-prostate
Resources:
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session: Head & neck cancer
Resources:
Slides
Webcast
Invited Discussant 1529MO, 930MO and 933MO
Presenter: Antonio Passaro
Session: Mini Oral session: Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Invited Discussant 1488MO, 1489MO and 1486MO
Presenter: Sebastian Bauer
Session: Mini Oral session: Sarcoma
Resources:
Slides
Webcast
Tools and clinical application of ctDNA in the adjuvant setting
Presenter: Solange Peters
Session: Creating a new stage between early and metastatic cancers: Illustration with lung cancers
Resources:
Slides
Webcast
317MO - Efficacy of oxaliplatin-based adjuvant chemotherapy in older patients with stage III colon cancer: An ACCENT/IDEA pooled analysis of 12 trials
Presenter: Claire Gallois
Session: Mini Oral session: GI, lower digestive
Resources:
Abstract
Slides
Webcast
625MO - Combination of mitoxantrone hydrochloride liposome with pegaspargase in patients with extranodal NK/T-cell lymphoma: A phase I/II clinical trial
Presenter: Yunhong Huang
Session: Mini Oral session: Haematological malignancies
Resources:
Abstract
Slides
Webcast
1447O - Phase II study of belzutifan plus cabozantinib as first-line treatment of advanced renal cell carcinoma (RCC): Cohort 1 of LITESPARK-003
Presenter: Jaime Merchan
Session: Proffered Paper session 2: GU tumours, non-prostate
Resources:
Abstract
Slides
Webcast
652O - Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same chemotherapy as first-line treatment for advanced nasopharyngeal carcinoma (NPC)
Presenter: Han Chong Toh
Session: Proffered Paper session: Head & neck cancer
Resources:
Abstract
Slides
Webcast
318MO - Circulating tumour DNA (ctDNA) dynamics, CEA and sites of recurrence for the randomised DYNAMIC study: Adjuvant chemotherapy (ACT) guided by ctDNA analysis in stage II colon cancer (CC)
Presenter: Jeanne Tie
Session: Mini Oral session: GI, lower digestive
Resources:
Abstract
Slides
Webcast